Cargando…
Drug Interactions of Psychiatric and COVID-19 Medications
INTRODUCTION: Coronavirus disease 2019 (COVID-19) has become a pandemic with 1771514 cases identified in the world and 70029 cases in Iran until April 12, 2020. The co-prescription of psychotropics with COVID-19 medication is not uncommon. Healthcare providers should be familiar with many Potential...
Autores principales: | Mohebbi, Niayesh, Talebi, Ali, Moghadamnia, Marjan, Nazari Taloki, Zahra, Shakiba, Alia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Neuroscience Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368108/ https://www.ncbi.nlm.nih.gov/pubmed/32855778 http://dx.doi.org/10.32598/bcn.11.covid19.2500.1 |
Ejemplares similares
-
Main challenges of electrolyte imbalance in older patients with COVID-19 and risk of QT prolongation
por: Rezazadeh, Amir, et al.
Publicado: (2021) -
Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications
por: Ghasemiyeh, Parisa, et al.
Publicado: (2021) -
Principales desafíos del desequilibrio electrolítico en pacientes geriátricos con COVID-19 y riesgo de prolongación del intervalo QT
por: Rezazadeh, Amir, et al.
Publicado: (2021) -
Drug interactions in elderly (Amirkola Health and Ageing Project)
por: Fath Tabar, Zahra, et al.
Publicado: (2022) -
Adverse drug events leading to emergency department visits at an eye hospital: A brief report
por: Alizadeh, Safa, et al.
Publicado: (2017)